Polypharmacy, medication adherence and medication management at home in elderly patients with multiple non-communicable diseases in Thai primary care

• Authors: Vatcharavongvan Pasitpon , Puttawanchai Viwat

Keywords

EN

aged; chronic diseases; polypharmacy; primary care; patient adherence.

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2017
• Issue: 4
• Pages: 412-416

Contributors

author

Vatcharavongvan Pasitpon

author

Puttawanchai Viwat

References

• Guthrie B, Makubate B, Hernandez-Santiago V, et al. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC medicine 2015; 13(1): 74, doi: 10.1186/s12916-015-0322-7.
• Herr M, Robine JM, Pinot J, et al. Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf 2015; 24(6): 637–646.
• Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany.Fam Pract 2007; 24(1): 14–19.
• Loya A, González-Stuart A, Rivera J. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border. Drugs Aging 2009; 26(5): 423–436.
• Slabaugh SL, Maio V, Templin M, et al. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna Region, Italy. Drugs Aging 2010; 27(12): 1019–1028.
• Ahmed B, Nanji K, Mujeeb R, et al. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study. PLoS ONE 2014; 9(11): e112133, doi: 10.1371/journal.pone.0112133.
• Payne RA, Avery AJ, Duerden M, et al. Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharmacol 2014; 70(5): 575–581.
• Maher RL, Hanlon JT, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014; 13(1): 57–65.
• Lenander C, Midlov P, Viberg N, et al. Use of antipsychotic drugs by elderly primary care patients and the effects of medication reviews:a cross-sectional study in Sweden. Drugs Real World Outcomes 2017; 4(3): 159–165.
• Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5(4): 345–351, doi: 10.1016/j. amjopharm.2007.12.002.
• Peron EP, Ogbonna KC, Donohoe KL. Antidiabetic medications and polypharmacy. Clin Geriatr Med 2015; 31(1): 17–27.
• Jyrkkä J, Enlund H, Korhonen M, et al. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons. Drugs Aging 2009; 26(6): 493–503.
• National Statistical Office. The 2014 survey of the older persons in Thailand. Bangkok: Text and Journal Publication; 2014.
• Aekplakorn W, Puckcharern H, Thaikla K, et al. Fifth national health examination survey 2014. Bangkok: National Health Research Institute; 2016.
• Sirois C, Laroche M-L, Guénette, L et al. Polypharmacy in multimorbid older adults: protocol for a systematic review. Syst Rev 2017; 6:104, doi: 10.1186/s13643-017-0492-9
• Leelakanok N, Holcombe AL, Lund BC, et al. Association between polypharmacy and death: a systematic review and meta-analysis. Am Pharm Assoc 2017; pii: S1544-3191(17)30714-8, doi: 10.1016/j.japh.2017.06.002 [Epub ahead of print].
• Haider S, Johnell K, Thorslund M, et al. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992–2002. Int J Clin Pharmacol Ther 2007; 45(12): 643–653.
• Fialová D, Topinková E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293(11): 1348–1358.
• Jörgensen T, Johansson S, Kennerfalk A, et al. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001; 35(9): 1004–1009.
• American Diabetes Association. Standards of medical care in diabetes – 2017: summary of revisions. Diabetes Care 2017; 40(Suppl.1): S4–S5.
• Patterson SM, Cadogan CA, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012; 5: CD008165, doi: 10.1002/14651858.CD008165.pub2.
• Lenander C, Bondesson A, Viberg N, et al. Effects of an intervention (SAKLAK) on prescription of potentially inappropriate medication in elderly patients. Fam Pract 2017; 34(2): 213–218.
• Lenander C, Bondesson A, Midlov P, et al. Healthcare system intervention for safer use of medicines in elderly patients in primary carea qualitative study of the participants’ perceptions of self-assessment, peer review, feedback and agreement for change. BMC Fam Pract 2015; 16: 117, doi: 10.1186/s12875-015-0334-6.
• Tamblyn R, Huang A, Perreault R, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ 2003; 169(6): 549–556.
• Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm 2003;60(11): 1123–1129.
• Moral RR, Torres LA, Ortega LP, et al. Effectiveness of motivational interviewing to improve therapeutic adherence in patients over 65 years old with chronic diseases: a cluster randomized clinical trial in primary care. Patient Educ Couns 2015; 98(8): 977–983.
• Sorensen L, Stokes JA, Purdie DM, et al. Medication management at home: medication-related risk factors associated with poor health outcomes. Age Ageing 2005; 34(6): 626–632.
• Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother 2009; 43(5): 950–907.